Indeed. Imagine coming to market a few years ago with what one might have deemed a promising product - they did raise several million dollars for it after all - only to see its focus fall to the wayside as the vaping 'hype' kicked in and took over, only for that to effectively be pushed to the side in favour of a resurrected core product now set to include a thermometer that will be bought from another company and integrated from a systems perspective. Not exactly leaps and bonds being made there.
Would you call any of that quality product development? Would you expect future quality development starting from a cash position estimated at $300k?
Ann: Change of Director's Interest Notice, page-31
-
- There are more pages in this discussion • 76 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.335M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 141666 | 2.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.0¢ | 398532 | 1 |
View Market Depth
| Last trade - 16.12pm 11/11/2024 (20 minute delay) ? |
| IRX (ASX) Chart |
Day chart unavailable